Dr. Peter McCullough On Ivermectin's Striking Anti-Cancer Potential

A drug used to treat intestinal parasites since the 1950s could play a key role in treating Merkel cell carcinoma, one of the rarest and most aggressive forms of skin cancer. A recent study has shown in preclinical models that the compound can inhibit tumor growth and reverse the aggressive characteristics of this type of skin cancer, offering a promising direction for the development of new therapies.

Dr. Peter McCullough On Ivermectin's Striking Anti-Cancer Potential

Renowned cardiologist Dr. Peter McCullough discusses groundbreaking research suggesting ivermectin's potential as an anti-cancer treatment, challenging conventional narratives and advocating for further clinical trials to validate its efficacy.

In a new study published in the Journal of Clinical Investigation, scientists have discovered that a drug used to treat pinworms can stop and reverse the growth of a form of skin cancer.

A drug against intestinal parasites, used since the 1950s, could play an essential role in the treatment of Merkel cell carcinoma, one of the rarest and most aggressive forms of cancer.